An Evening of BrightFocus brought more than 250 guests from the scientific, philanthropic, private, and public sectors together in Washington in June 2017 to celebrate promising science and bold advocacy to end Alzheimer’s disease, macular degeneration, and glaucoma.
The event was hosted by entertainer Keith Carradine, who later in the evening joined his brother, Robert Carradine, for a special musical performance.
Recognized that evening:
- George Vradenburg and Trish Vradenburg (posthumously) received the BrightFocus Award® for Public Leadership for their years of work and commitment to end Alzheimer’s.
- Joe Hollyfield, PhD, received the BrightFocus Award® for Scientific Impact for his research in macular degeneration.
- Jennifer R. Gatchel, MD, PhD, was recognized as an outstanding emerging researcher in the field of Alzheimer’s disease.
Honorees to Date
Public Leadership Award
2017 George and Trish Vradenburg, Co-founders
2016 Meryl Comer, President and CEO
Geoffrey Beene Foundation Alzheimer’s Initiative
Scientific Impact Award
2017 Joe G. Hollyfield, PhD, Chairman, Ophthalmic Research
Cleveland Clinic Cole Eye Institute
2016 Stanley B. Prusiner, MD, Director of the Institute for Neurodegenerative Diseases and Professor of Neurology and Biochemistry, University of California, San Francisco.
Spotlight: Emerging Researcher
2017 Jennifer R. Gatchel, MD, PhD, Instructor in Psychiatry
Harvard Medical School, Massachusetts General Hospital
Cocktails with the Scientists
Guests had the opportunity to interact informally with seven BrightFocus-funded scientists who discussed their research at learning stations throughout the reception area.
Left to Right:
Kaustabh Ghosh, PhD, University of California, Riverside
Understand precisely how aging increases the risk for macular degeneration
Chris Passaglia, PhD, University of South Florida
Learn about new technologies being developed to understand the causes and effects of glaucoma
Alfred Lewin, PhD, University of Florida
Old dogs learning new tricks: repurposing drugs for the treatment of age related macular degeneration
Yona Levites, PhD, University of Florida
The future generation of immunotherapy for Alzheimer’s disease
Jennifer R. Gatchel, MD, PhD, Harvard
Learn about (and see!) changes in the brain that track with mood and memory in Alzheimer’s disease
Pietro Michelucci, PhD, Human Computation Institute
Witness the power of crowds: help analyze Alzheimer's data by playing an online game
J. Crawford Downs, PhD, University of Alabama at Birmingham
See how dynamic pressures in the eye and brain provide a new framework for understanding glaucoma